Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7479d7b7d-767nl Total loading time: 0 Render date: 2024-07-10T23:39:44.097Z Has data issue: false hasContentIssue false

Chapter 60 - Sneddon Syndrome

from Section 6 - Systemic Disorders That Also Involve the Cerebrovascular System

Published online by Cambridge University Press:  15 June 2018

By
Jacques L. De Reuck
Edited by
Louis Caplan  and
José Biller
Louis Caplan
Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller
Affiliation:
Loyola University Stritch School of Medicine, Chicago
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Uncommon Causes of Stroke , pp. 482 - 488
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adair, J. C., Digre, K. B., Swanda, R. M., et al. 2001. Sneddon’s syndrome: A cause of cognitive decline in young adults. Neuropsychiatry Neuropsychol Behav Neurol, 14, 197–204.Google Scholar
Alegre, V. A., Winkelmann, R. K., and Gastineau, D. A. 1990. Cutaneous thrombosis, cerebrovascular thrombosis, and lupus anticoagulant: The Sneddon syndrome. Int J Dermatol, 29, 45–9.CrossRefGoogle ScholarPubMed
Antoine, J. C., Michel, D., Garnnier, P., et al. 1994. Syndrome de Sneddon: 9 cas. Rev Neurol (Paris), 150, 435–43.Google Scholar
Ayoub, N., Esposito, G., Barete, S., et al. 2004. Protein Z deficiency in antiphospholipid-negative Sneddon’s syndrome. Stroke, 35, 1329–32.Google Scholar
Baleva, M., Chauchev, A., Dikova, C., et al. 1995. Sneddon’s syndrome: Echocardiographic, neurological, and immunological findings. Stroke, 26, 1303–4.Google Scholar
Berciano, J. 1988. Sneddon syndrome: Another Mendelian etiology of stroke. Ann Neurol, 24, 586–7.Google Scholar
Besnier, R., Frances, C., Ankri, A., Aiach, M., and Piette, J. C. 2003. Factor V Leiden mutation in Sneddon syndrome. Lupus, 12, 406–8.CrossRefGoogle ScholarPubMed
Bladin, C., Alexandrov, A., Bellevance, A., et al., for the Seizures After Stroke Study Group. 2000. Seizures after stroke. A prospective multicenter study. Arch Neurol, 57, 1617–22.Google Scholar
Boesch, S. M., Plorer, A. L., Auer, A. J., et al. 2003. The natural course of Sneddon syndrome: Clinical and magnetic resonance imaging findings in a prospective six year observation study. J Neurol Neurosurg Psychiatry, 74, 542–4.Google Scholar
Boortz-Marx, R. L., Clark, H. B., Taylor, S., Wesa, K. M., and Anderson, D. C. 1995. Sneddon’s syndrome with granulomatous leptomeningeal infiltration. Stroke, 26, 492–5.Google Scholar
Bottin, L., Francés, C., de Zuttere, D., et al. 2015. Strokes in Sneddon syndrome without antiphospholipid antibodies. Ann Neurol, 77, 817–29.Google Scholar
Bras, J, Guerreiro, R, Santo, GC, 2014. Mutant ADA2 in vasculopathies. N Eng J Med, 371, 478–80Google Scholar
Caplan, L. R. and Manning, W. J. 2006. Cardiac sources of embolism: The usual suspects. In Brain Embolism, Caplan, L. R. and Manning, W. J. (eds.), New York: Informa Healthcare, pp. 129–59.Google Scholar
Daoud, M. S., Wilmoth, G. J., Su, W. P. D., and Pittelkow, M. R. 1995. Sneddon syndrome. Semin Dermatol, 14, 166–72.CrossRefGoogle ScholarPubMed
Da Silva, A. M., Rocha, N., Pinto, M., et al. 2005. Tremor as the first neurological manifestation of Sneddon’s syndrome. Mov Dis, 20, 248–51.Google Scholar
De Reuck, J., De Reus, R., and De Koninck, J. 1987. Sneddon’s syndrome. A not unusual cause of stroke in young women. In Cerebral Vascular Disease 6. Proceedings of the World Federation of Neurology 13th International Salzburg Conference, Meyer, J. S., Lechner, H., Reivich, M., and Ott, E. O. (eds.), Amsterdam: Excerpta Medica, pp. 171–4.Google Scholar
De Reuck, J., Goethals, M., Vonck, K., and Van Maele, G. 2005. Clinical predictors of late-onset seizures and epilepsy in patients with cerebrovascular disease. Eur Neurol, 54, 68–72.Google Scholar
De Reus, R., De Reuck, J., Vermander, F., Kint, A., and Van de Velde, E. 1985. Livedo racemosa generalisata and stroke. Clin Neurol Neurosurg, 87, 143–8.CrossRefGoogle ScholarPubMed
Donders, R., Kappelle, L. J., Derksen, R., et al. 1998. Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus. Neurology, 51, 535–40.CrossRefGoogle ScholarPubMed
Dupont, S., Fénelon, G., Saiag, P., and Sirmai, J. 1996. Warfarin in Sneddon’s syndrome. Neurology, 46, 1781–2.Google Scholar
Floel, A., Imai, T., Lohmann, H., et al. 2002. Therapy of Sneddon syndrome. Eur Neurol, 48, 126–32.CrossRefGoogle ScholarPubMed
Frances, C. and Piette, J. C. 2000. The mystery of Sneddon syndrome: Relationship with antiphospholipid syndrome and systemic lupus erythematosus. J Autoimmunol, 15, 139–43.CrossRefGoogle ScholarPubMed
Geschwind, D., FitzPatrick, M., Mischel, P., and Cummings, J. 1995. Sneddon’s syndrome is a thrombotic vasculopathy: Neuropathologic and neuroradiologic evidence. Neurology, 45, 557–60.Google Scholar
Gibson, G. E., Su, W. P., and Pittelkow, M. R. 1997. Antiphospholipid syndrome and the skin. J Am Acad Dermatol, 36, 970–82.Google Scholar
Hachulla, E., Piette, A. M., Hatron, P. Y., and Blétry, O. 2000. Aspirin and antiphospholipid syndrome. Rev Med Interne, 21(Suppl 1), 83–8s.Google Scholar
Hilton, D. A. and Footitt, D. 2003. Neuropathological findings in Sneddon’s syndrome. Neurology, 60, 1181–2.Google Scholar
Kalashnikova, L. A., Korczyn, A. D., Shavit, S., et al. 1999. Antibodies to prothrombin in patients with Sneddon’s syndrome. Neurology, 53, 223–5.Google Scholar
Khamashta, M. A., Cuadrado, M. J., Mujic, F., et al. 1995. The management of thrombosis in the antiphospholipid syndrome. N Engl J Med, 332, 993–7.Google Scholar
Khoo, L. A., and Belli, A. M. 1999. Superior mesenteric artery stenting for mesenteric ischaemia in Sneddon’s syndrome. Br J Radiol, 72, 607–9.CrossRefGoogle ScholarPubMed
Kraemer, M., Linden, D., and Berlit, P. 2005. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review. J Neurol, 252, 1155–66.Google Scholar
Krnic-Barrie, S., O’Connor, C. R., Looney, S. W., Pierangeli, S. S., and Harris, E. N. 1997. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Arch Intern Med, 157, 2101–8.Google Scholar
Lewandowska, E., Wierzba-Bobrowicz, T., Wagner, T., et al. 2005. Sneddon’s syndrome as a disorder of small arteries with endothelial cells proliferation: Ultrastructural and neuroimaging study. Folia Neuropathol, 43, 345–54.Google Scholar
Lockshin, M. D. 1992. Antiphospholipid antibody syndrome. JAMA, 268, 1451–3.CrossRefGoogle ScholarPubMed
Lubach, D., Schwabe, C., Weissenborn, K., et al. 1992. Livedo racemosa generalisata: An evaluation of thirty-four cases. Stroke, 23, 1182–3.Google Scholar
Macario, F., Macario, M. C., Ferro, A., et al. 1997. Sneddon’s syndrome: A vascular systemic disease with kidney involvement? Nephron, 75, 94–7.Google Scholar
Martinez-Menendez, B., Perez-Sempere, A., Gonzalez-Rubio, M., et al. 1990. Sneddon’s syndrome with negative antiphospholipid antibodies. Stroke, 21, 1510–1.Google Scholar
Matsumura, Y., Tomimoto, H., Yamamoto, M., Imamura, S., and Miyachi, Y. 2001. Sneddon syndrome with multiple cerebral infarctions 12 years after the onset of livedo vasculitis: A possible involvement of platelet activation. J Dermatol, 28, 508–10.CrossRefGoogle ScholarPubMed
Menzel, C., Reinhold, U., Grunwald, F., et al. 1994. Cerebral blood flow in Sneddon syndrome. J Nucl Med, 35, 461–4.Google Scholar
Michel, M., Bourquelot, P., and Hermine, O. 1996. Essential thrombocythaemia: a cause of Sneddon’s syndrome. Lancet, 347, 395.CrossRefGoogle ScholarPubMed
Moral, A., Vidal, J. M., Moreau, I., Olhaberriague, L., and Montalban, J. 1991. Sneddon’s syndrome with antiphospholipid antibodies and arteriopathy. Stroke, 22, 1327–8.CrossRefGoogle ScholarPubMed
Pauranik, A., Parwani, S., and Jain, S. 1987. Simultaneous bilateral central retinal artery occlusion in a patient with Sneddon syndrome: Case history. J Vasc Dis, 12, 158–63.Google Scholar
Pettee, A. D., Wasserman, B. A., Adams, N. L., et al. 1994. Familial Sneddon’s syndrome. Clinical, hematological, and radiographic findings in two brothers. Neurology, 44, 399–405.Google Scholar
Pinol-Aguade, J., Ferrandiz, C., Ferrer-Roca, O., and Ingelmo, M. 1999. Livedo reticularis y accidentes cerebrovasculares. Med Cutan Ibero Lat Am, 3, 257–65.Google Scholar
Rebollo, M., Val, J. F., Garijo, F., Quintana, F., and Berg, E. L. 1983. Livedo reticularis and cerebrovascular lesions (Sneddon’s syndrome). Brain, 106, 965–79.Google Scholar
Rehany, U., Kassif, Y., and Rumelt, S. 1998. Sneddon’s syndrome: Neuro-ophthalmologic manifestations in a possible autosomal recessive pattern. Neurology, 51, 1185–7.CrossRefGoogle Scholar
Rosenberg, R. D., and Aird, W. C. 1999. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med, 340, 1555–64.Google Scholar
Ruscalleda, J., Coscojuela, P., Guardia, E., and De Juan, M. 1991. General case of the day. Radiographics, 11, 929–31.Google Scholar
Scheuermann, S. and Schlundt, C. 2014. STEMI of the anterior wall associated with Sneddon’s syndrome. Herz, 39, 352–3.CrossRefGoogle ScholarPubMed
Schellong, S. M., Weissenborn, K., Niedermeyer, J., et al. 1997. Vasa, 26, 215–21.Google Scholar
Serrano-Pozo, A., Gomez-Aranda, F., Franco-Macias, E., and Serrano-Cabrera, A. 2004. Cerebral haemorrhage in Sneddon’s syndrome: Case report and literature review. Rev Neurol, 39, 731–3.Google ScholarPubMed
Sitzer, M., Sohngen, D., Siebler, M., et al. 1995. Cerebral microembolism in patients with Sneddon’s syndrome. Arch Neurol, 52, 271–5.Google Scholar
Sneddon, I. B. 1965. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol, 77, 777–82.Google Scholar
Stephens, W. P. and Ferguson, I. T. 1982. Livedo reticularis and cerebro-vascular disease. Postgrad Med J, 58, 70–3.Google Scholar
Sun, J., Zhang, F., Gao, F., Wang, J., Selim, M., and Lou, M. 2012. Intravenous thrombolysis in Sneddon’s syndrome. J Clin Neurosci, 19, 326–8.CrossRefGoogle ScholarPubMed
Szmyrka-Kaczmarek, M., Daikeler, T., Benz, D., and Koetter, I. 2005. Familial inflammatory Sneddon’s syndrome-case report and review of the literature. Clin Rheumatol, 24, 79–82.Google Scholar
Tanne, D., Triplett, D. A., and Levine, S. R. 1998. Antiphospholipid-protein antibodies and ischemic stroke. Not just cardiolipin anymore. Stroke, 29, 1755–8.Google Scholar
Thomas, D. J., Kirby, J. D. T., Britton, K. E., and Galton, D. J. 1982. Livedo reticularis and neurological lesions. Br J Dermatol, 106, 711–2.Google Scholar
Tietjen, G., Al-Qasmi, M., Gunda, P., and Herial, N. 2006. Sneddon’s syndrome: Another migraine–stroke association? Cephalgia, 26, 225–32.Google Scholar
Toubi, E., Krause, I., Fraser, A., Lev, S., et al. 2005. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol, 23, 499–504.Google Scholar
Tourbah, A., Piette, J., Iba-Zizen, M. T., et al. 1997. The natural course of cerebral lesions in Sneddon’s syndrome. Arch Neurol, 54, 53–60.Google Scholar
Wohlrab, J., Fischer, M., Wolter, M., and Marsch, W. C. 2001. Diagnostic impact and sensitivity of skin biopsies in Sneddon’s syndrome. A report of 15 cases. Br J Dermatol, 145, 285–8.Google Scholar
Zelger, B., Sepp, N., Stockhammer, G., et al. 1993. Sneddon’s syndrome. A long-term follow-up of 21 patients. Arch Neurol, 129, 437–47.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×